Integral Diagnostics slams Capitol Health’s ‘opportunistic’ bid

SYDNEY: Integral Diagnostics is urging shareholders to reject the $312 million cash and scrip bid

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In